204 related articles for article (PubMed ID: 38770138)
1. Unleashing the Power of Proenzyme Delivery for Targeted Therapeutic Applications Using Biodegradable Lipid Nanoparticles.
Zheng Q; Ma T; Wang M
Acc Chem Res; 2024 Jan; 57(2):208-221. PubMed ID: 38143330
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders.
Chu R; Wang Y; Kong J; Pan T; Yang Y; He J
J Mater Chem B; 2024 May; 12(20):4759-4784. PubMed ID: 38682294
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent Labeling and Imaging of IL-22 mRNA-Loaded Lipid Nanoparticles.
Mow RJ; Srinivasan A; Bolay E; Merlin D; Yang C
Bio Protoc; 2024 May; 14(10):e4994. PubMed ID: 38798981
[TBL] [Abstract][Full Text] [Related]
4. Effects of Histidine Oligomers in Lipid Nanoparticles on siRNA Delivery.
Lee H; You G; Yeo S; Lee H; Mok H
Macromol Biosci; 2024 May; ():e2400043. PubMed ID: 38819534
[TBL] [Abstract][Full Text] [Related]
5. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system.
Parhiz H; Shuvaev VV; Li Q; Papp TE; Akyianu AA; Shi R; Yadegari A; Shahnawaz H; Semple SC; Mui BL; Weissman D; Muzykantov VR; Glassman PM
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102175. PubMed ID: 38576454
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the therapeutic potential of locked nucleic acids through lipid nanoparticle delivery.
Qassem S; Breier D; Naidu GS; Hazan-Halevy I; Peer D
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102224. PubMed ID: 38933259
[TBL] [Abstract][Full Text] [Related]
7. Natural lignin nanoparticles target tumor by saturating the phagocytic capacity of Kupffer cells in the liver.
Huo CM; Zuo YC; Chen Y; Chen L; Zhu JY; Xue W
Int J Biol Macromol; 2024 Jun; 274(Pt 2):133186. PubMed ID: 38885858
[TBL] [Abstract][Full Text] [Related]
8. Leveraging high-throughput screening technologies in targeted mRNA delivery.
Zhang Y; Gao Z; Yang X; Xu Q; Lu Y
Mater Today Bio; 2024 Jun; 26():101101. PubMed ID: 38883419
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles-based RNA therapies for breast cancer treatment.
Serpico L; Zhu Y; Maia RF; Sumedha S; Shahbazi MA; Santos HA
Drug Deliv Transl Res; 2024 Jun; ():. PubMed ID: 38831199
[TBL] [Abstract][Full Text] [Related]
10. A tale of nucleic acid-ionizable lipid nanoparticles: Design and manufacturing technology and advancement.
De A; Ko YT
Expert Opin Drug Deliv; 2023 Jan; 20(1):75-91. PubMed ID: 36445261
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
Jeong M; Lee Y; Park J; Jung H; Lee H
Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
[TBL] [Abstract][Full Text] [Related]
12. Optimized lipid nanoparticles (LNPs) for organ-selective nucleic acids delivery
Zhang T; Yin H; Li Y; Yang H; Ge K; Zhang J; Yuan Q; Dai X; Naeem A; Weng Y; Huang Y; Liang XJ
iScience; 2024 Jun; 27(6):109804. PubMed ID: 38770138
[TBL] [Abstract][Full Text] [Related]
13. Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid.
Jia Y; Wang X; Li L; Li F; Zhang J; Liang XJ
Adv Mater; 2024 Jan; 36(4):e2305300. PubMed ID: 37547955
[TBL] [Abstract][Full Text] [Related]
14. Chemistry of Lipid Nanoparticles for RNA Delivery.
Eygeris Y; Gupta M; Kim J; Sahay G
Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
Mukai H; Ogawa K; Kato N; Kawakami S
Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
